Company intelligence / Profile preview

Morepen Laboratories

Gurugram, Haryana, Indiamorepen.com ↗

Ownership: Private
Employees: ~2300
Development stage: Other

Overview

Morepen Laboratories has a robust commercial portfolio of APIs for major global markets with USFDA/EU GMP approvals. It supplies key APIs such as loratadine and montelukast to leading pharma companies worldwide. The company also manufactures finished formulations and a wide range of OTC/home diagnostic products for both domestic and international markets[1][2][3].

Therapeutic areas: PsychiatryPulmonologyInfectious DiseasesGastroenterologyEndocrinologyImmunologyCardiovascular
Modalities: Small moleculeDevice
Industry: Biotech

Drug pipeline

1 asset

Melocin

Discontinued

Partnerships

ApotexNovex PharmaGenpharmNovopharmTechnilabImmucor USATeco Medical Instruments GermanyInTec Inc.Access Bio USA

Beyond the preview

Go deeper on Morepen Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Morepen Laboratories.

Explore the full profile